Sarah Cannon Research Institute (SCRI) at HealthONE
1800 Williams Street, Suite 300, Denver, CO 80218 | Phone: 720-754-2610
The HealthONE family of hospitals and the Sarah Cannon Cancer Network of Excellence are proud to announce the new Sarah Cannon Research Institute (SCRI) at HealthONE. SCRI at HealthONE is located at 1800 Williams St. in Denver, Colorado, near Presbyterian/St. Luke’s Medical Center.
SCRI at HealthONE will conduct innovative cancer clinical trials, never before available to patients in a community setting, that will serve patients throughout the region. SCRI at HealthONE is directed by Gerald Falchook, M.D., who has been the principal investigator or co-investigator on more than 160 cancer clinical studies. His research has been published extensively in peer-reviewed journals. Sarah Cannon Research Institute at HealthONE is part of a larger research network, with affiliations with hospitals and physicians in the United States and United Kingdom. Sarah Cannon has had a leadership role in nearly every breakthrough anticancer drug approved in the last 7 years.
The SCRI is the latest development in the partnership between the HealthONE facilities and the nationally recognized Sarah Cannon Cancer Network. We are fighting cancer together. HealthONE hospitals, physicians and staff along with the Sarah Cannon team enhance cancer research, diagnosis, treatment and patient-focused services for our patients. To learn more about SCRI at HealthONE (click here), or the partnership between the HealthONE hospitals and Sarah Cannon, please (click here).